Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application

被引:154
|
作者
von Bergwelt-Baildon, MS
Vonderheide, RH
Maecker, B
Hirano, N
Anderson, KS
Butler, MO
Xia, ZN
Zeng, WY
Wucherpfennig, KW
Nadler, LM
Schultze, JL
机构
[1] Univ Cologne, Dept Hematol Oncol, Tumor Immunol Lab, D-50924 Cologne, Germany
[2] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
关键词
D O I
10.1182/blood.V99.9.3319
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CD40 engagement is the major signal that induces B cells to efficiently present antigen to T cells. We previously demonstrated that human peripheral blood-derived CD40-activated B cells (CD4D-B cells) function as antigen-presenting cells (APCs). Here, we have established a culture system to generate these APCs under clinically applicable conditions using guanylic acid-grade soluble trimeric CD40 ligand. To monitor APC function and antigen loading for these cells, simple and efficient quality control assays have been developed. Using this approach, we demonstrate that CD40-B cells from healthy donors and cancer patients are fully functional and equally expanded in long-term cultures. These B cells boost robust memory T-cell responses, but more importantly, they also prime naive T-cell responses against neoantigens ex vivo. CD40-B cells overcome current obstacles, such as the difficulty of isolation, generation, and long-term expansion observed with other APCs. Therefore, they are an excellent source of professional APCs for immune assessment, antigen discovery, and antigen-specific immunotherapy. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:3319 / 3325
页数:7
相关论文
共 50 条
  • [11] The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells
    Shimabukuro-Vornhagen, Alexander
    Draube, Andreas
    Liebig, Tanja M.
    Rothe, Achim
    Kochanek, Matthias
    von Bergwelt-Baildon, Michael S.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [12] Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses
    Li, Hua
    Shao, Shengwen
    Cai, Jianshu
    Burner, Danielle
    Lu, Lingeng
    Chen, Qiuqiang
    Minev, Boris
    Ma, Wenxue
    IMMUNOLOGY, 2017, 152 (03) : 462 - 471
  • [13] PHOSPHORYLATION OF THE CD8 ANTIGEN ON CYTOTOXIC HUMAN T-CELLS IN RESPONSE TO PHORBOL-MYRISTATE ACETATE OR ANTIGEN-PRESENTING B-CELLS
    ACRES, RB
    CONLON, PJ
    MOCHIZUKI, DY
    GALLIS, B
    JOURNAL OF IMMUNOLOGY, 1987, 139 (07): : 2268 - 2274
  • [14] Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells
    Dupont, J
    Latouche, JB
    Ma, C
    Sadelain, N
    CANCER RESEARCH, 2005, 65 (12) : 5417 - 5427
  • [15] Artificial antigen-presenting cells plus IL-15 and IL-21 efficiently induce melanoma-specific cytotoxic CD8+CD28+T lymphocyte responses
    Lu, Xiaoling
    Zhao, Yongxiang
    Zhou, Nuo
    Yu, Xia
    He, Jian
    Mongkhoune, Sodaly
    Peng, Yi
    Xie, Yu An
    Zhou, Sufang
    Xie, Xiaoxun
    Luo, Guorong
    Li, Xi
    Fang, Yuan
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [16] Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells
    Lefrançois, L
    Altman, JD
    Williams, K
    Olson, S
    JOURNAL OF IMMUNOLOGY, 2000, 164 (02): : 725 - 732
  • [17] Artificial antigen-presenting cells plus IL-15 and IL-21 efficiently induce melanoma-specific cytotoxic CD8~+CD28~+ T lymphocyte responses
    Xia Yu
    Jian He
    Sodaly Mongkhoune
    Yi Peng
    Yuan Xie
    Jing Su
    Su-Fang Zhou
    Xiao-Xun Xie
    Guo-Rong Luo
    Yuan Fang
    Xi Li
    Nuo Zhou
    Yong-Xiang Zhao
    Xiao-Ling Lu
    Asian Pacific Journal of Tropical Medicine, 2013, (06) : 467 - 472
  • [18] Activated primary human B cells efficiently induce early CD40L and CD107a expression in CD4+ T cells
    Theurich, Sebastian
    Malcher, Joke
    Becker, Hans J.
    Chemnitz, Jens M.
    Liebig, Tanja M.
    Shimabukuro-Vornhagen, Alexander
    von Bergwelt-Baildon, Michael
    BLOOD, 2011, 118 (22) : 5979 - 5980
  • [19] REDUCED LYSIS BY CD8(+) CYTOTOXIC T-CELLS IN MIXED LYMPHOCYTE REACTIONS INDUCED VIA CD4(+) T-CELLS EXPOSED TO CHEMICALLY-MODIFIED ANTIGEN-PRESENTING CELLS
    CORLETT, L
    DAVIES, DH
    IMMUNOLOGY, 1995, 84 (03) : 488 - 494
  • [20] RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma
    Mason, N. J.
    Coughlin, C. M.
    Overley, B.
    Cohen, J. N.
    Mitchell, E. L.
    Colligon, T. A.
    Clifford, C. A.
    Zurbriggen, A.
    Sorenmo, K. U.
    Vonderheide, R. H.
    GENE THERAPY, 2008, 15 (13) : 955 - 965